financetom
Business
financetom
/
Business
/
Eyeing the Pacific, Lockheed unveils low-cost $150,000 cruise missile
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Eyeing the Pacific, Lockheed unveils low-cost $150,000 cruise missile
Mar 3, 2025 11:03 AM

WASHINGTON (Reuters) - Lockheed Martin ( LMT ) plans to unveil a new "affordable" cruise missile on Monday with a cost of about $150,000 and a range of over 500 miles (800 km) as the defense contractor works to tap a U.S. need to deter Chinese ambitions in the Pacific.

Russia's invasion of Ukraine has pushed U.S. and other countries' thinking about armaments toward a new strategy known as "affordable mass," meaning having plenty of relatively cheap weapons at the ready.

The Common Multi-Mission Truck (CMMT) missile concept is a new product that aims to develop a family of low-cost modular weapons from Lockheed and its partners' existing catalog of components.

The CMMT missile is designed to fill a gap between lower-cost standoff glide weapons and more expensive cruise missiles, Scott Callaway, Director, Affordable Mass, Lockheed Martin Missiles and Fire Control told Reuters in a recent interview.

If the Pentagon decides to buy the new offering, Callaway said Lockheed could make 2,500 a year - once a production line was running.

CMMT is "a subsonic, low-cost, long-range cruise missile," Callaway said. Its low-cost turbine engines cannot, however, compete with cruise missiles such as Lockheed's AGM-158 Joint Air-to-Surface Standoff Missile.

The JASSM is a 1,000-pound missile costing over $1.5 million per item.

The industrial scale of the war in Ukraine has highlighted the necessity for deeper inventories of relatively inexpensive weapons.

CMMT is designed to be modular, allowing for diverse variants to meet various mission requirements.

These include a longer-range version - deployable from aircraft like the C-17, fighters and bombers - as well as a shorter-range version.

A maritime strike variant is also envisioned, potentially to be employed in swarms with varying seeker mechanisms for greater effectiveness.

Callaway said Lockheed Martin ( LMT ) was aiming to sell the basic air vehicle for $150,000 per unit, which it considered competitive.

The United States is amassing an arsenal of abundant and easily-made anti-ship weapons as part of efforts to push back against Chinese assertiveness in the Indo-Pacific region.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Coherent Insider Sold Shares Worth $948,505, According to a Recent SEC Filing
Coherent Insider Sold Shares Worth $948,505, According to a Recent SEC Filing
Jun 6, 2024
04:51 PM EDT, 06/06/2024 (MT Newswires) -- Michael L Dreyer, Director, on June 05, 2024, sold 14,239 shares in Coherent (COHR) for $948,505. Following the Form 4 filing with the SEC, Dreyer has control over a total of 18,552 shares of the company, with 18,552 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/820318/000082031824000012/xslF345X03/primary_doc.xml Price: 65.98, Change: -0.14, Percent Change: -0.21 ...
FS KKR Capital Closes $600 Million Offering of Notes Due 2029
FS KKR Capital Closes $600 Million Offering of Notes Due 2029
Jun 6, 2024
04:58 PM EDT, 06/06/2024 (MT Newswires) -- FS KKR Capital ( FSK ) said Thursday it completed a $600 million public offering of 6.875% unsecured notes due 2029. Net proceeds from the offering will be used for general corporate purposes, including debt repayment, the company said. Price: 20.62, Change: +0.05, Percent Change: +0.24 ...
Biomea Reports Diabetes Drug Candidate Placed on Clinical Hold
Biomea Reports Diabetes Drug Candidate Placed on Clinical Hold
Jun 6, 2024
04:56 PM EDT, 06/06/2024 (MT Newswires) -- Biomea Fusion ( BMEA ) said Thursday it received a notice from the US Food and Drug Administration that a full clinical hold has been placed on its phase I/II trials of its investigational covalent menin inhibitor BMF-219 in type 2 and type 1 diabetes. The FDA cited deficiencies based on the level...
Mckesson Insider Sold Shares Worth $2,155,761, According to a Recent SEC Filing
Mckesson Insider Sold Shares Worth $2,155,761, According to a Recent SEC Filing
Jun 6, 2024
04:51 PM EDT, 06/06/2024 (MT Newswires) -- Brian S. Tyler, Director, Chief Executive Officer, on June 05, 2024, sold 3,753 shares in Mckesson (MCK) for $2,155,761. Following the Form 4 filing with the SEC, Tyler has control over a total of 90,059 shares of the company, with 89,845 shares held directly and 214 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/927653/000106299324012074/xslF345X03/form4.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved